Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · IEX Real-Time Price · USD
1.190
+0.020 (1.71%)
At close: Apr 25, 2024, 4:00 PM
1.240
+0.050 (4.20%)
After-hours: Apr 25, 2024, 7:43 PM EDT
Aclaris Therapeutics Stock Forecast
ACRS's stock price has decreased by -86.7% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ACRS stock have an average target of 11.5, with a low estimate of 1.00 and a high estimate of 22. The average target predicts an increase of 866.39% from the current stock price of 1.19.
Analyst Consensus: Hold
* Price targets were last updated on Dec 18, 2023.
Analyst Ratings
The average analyst rating for ACRS stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 22, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +656.30% | Dec 29, 2023 |
| Stifel | Stifel | Hold Maintains $2 → $1 | Hold | Maintains | $2 → $1 | -15.97% | Dec 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $9 | Strong Buy | Maintains | $43 → $9 | +656.30% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
5.70M
from 31.25M
Decreased by -81.77%
Revenue Next Year
6.12M
from 5.70M
Increased by 7.46%
EPS This Year
-1.01
from -1.27
EPS Next Year
-0.84
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.9M | 8.2M | 10.6M | 51.9M | 122.9M |
| Avg | 5.7M | 6.1M | 6.2M | 21.3M | 55.8M |
| Low | 2.2M | 2.2M | 2.2M | 6.8M | 6.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -74.9% | 43.8% | 73.3% | 735.7% | 477.6% |
| Avg | -81.8% | 7.5% | 1.4% | 242.6% | 162.3% |
| Low | -92.9% | -61.0% | -63.7% | 8.9% | -67.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.34 | -0.33 | -0.33 | -0.62 | -0.60 |
| Avg | -1.01 | -0.84 | -0.82 | -1.59 | -1.47 |
| Low | -1.32 | -1.46 | -1.41 | -3.11 | -2.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.